The FDA has approved the first drug designed using 3D-printing technology
SPRITAM’s 3D-printed designed makes it water soluble with a minimal amount of liquid, which absorbs into the blood stream in less than 10 seconds.“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” Don Wetherhold, Aprecia’s Chief Executive Officer of Aprecia, said in a press release.
No comments:
Post a Comment